383 related articles for article (PubMed ID: 20025697)
21. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
[TBL] [Abstract][Full Text] [Related]
22. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.
Alexander ME; Cecchin F; Walsh EP; Triedman JK; Bevilacqua LM; Berul CI
J Cardiovasc Electrophysiol; 2004 Jan; 15(1):72-6. PubMed ID: 15028076
[TBL] [Abstract][Full Text] [Related]
23. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
[TBL] [Abstract][Full Text] [Related]
24. ICD therapy in children and young adults: low incidence of inappropriate shock delivery.
Botsch MP; Franzbach B; Opgen-Rhein B; Berger F; Will JC
Pacing Clin Electrophysiol; 2010 Jun; 33(6):734-41. PubMed ID: 20149121
[TBL] [Abstract][Full Text] [Related]
25. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
[TBL] [Abstract][Full Text] [Related]
26. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
[TBL] [Abstract][Full Text] [Related]
27. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.
Trappe HJ; Pfitzner P; Achtelik M; Fieguth HG
Heart; 1997 Oct; 78(4):364-70. PubMed ID: 9404252
[TBL] [Abstract][Full Text] [Related]
28. [The implantable cardioverter-defibrillator: the Portuguese experience].
Adragão P; Neves J; Sousa J; Fançoni J; da Silva N; Antunes E; Elvas L; Bernardo J
Rev Port Cardiol; 1997 Apr; 16(4):367-74, 351-2. PubMed ID: 9254126
[TBL] [Abstract][Full Text] [Related]
29. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease.
Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA
Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513
[TBL] [Abstract][Full Text] [Related]
30. Congenital long QT 3 in the pediatric population.
Blaufox AD; Tristani-Firouzi M; Seslar S; Sanatani S; Trivedi B; Fischbach P; Paul T; Young ML; Tisma-Dupanovic S; Silva J; Cuneo B; Fournier A; Singh H; Tanel RE; Etheridge SP
Am J Cardiol; 2012 May; 109(10):1459-65. PubMed ID: 22360817
[TBL] [Abstract][Full Text] [Related]
31. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
[TBL] [Abstract][Full Text] [Related]
32. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?
Rhee EK; Canter CE; Basile S; Webber SA; Naftel DC
J Heart Lung Transplant; 2007 May; 26(5):447-52. PubMed ID: 17449412
[TBL] [Abstract][Full Text] [Related]
33. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score.
van Rees JB; Borleffs CJ; van Welsenes GH; van der Velde ET; Bax JJ; van Erven L; Putter H; van der Bom JG; Schalij MJ
Heart; 2012 Jun; 98(11):872-7. PubMed ID: 22581736
[TBL] [Abstract][Full Text] [Related]
34. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
[TBL] [Abstract][Full Text] [Related]
35. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death].
van den Berg MP; van Tintelen JP; van Dessel PF; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2132-5. PubMed ID: 15553359
[TBL] [Abstract][Full Text] [Related]
36. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
[TBL] [Abstract][Full Text] [Related]
37. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.
Alter P; Waldhans S; Plachta E; Moosdorf R; Grimm W
Pacing Clin Electrophysiol; 2005 Sep; 28(9):926-32. PubMed ID: 16176531
[TBL] [Abstract][Full Text] [Related]
38. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
[TBL] [Abstract][Full Text] [Related]
39. Implantable cardioverter-defibrillators in children.
Werner B; Przybylski A; Kucińska B; Lewandowski M; Szwed H; Wróblewska-Kałuzewska M
Kardiol Pol; 2004 Mar; 60(3):239-46. PubMed ID: 15156219
[TBL] [Abstract][Full Text] [Related]
40. Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up.
Mönnig G; Köbe J; Löher A; Wasmer K; Milberg P; Zellerhoff S; Pott C; Zumhagen S; Radu R; Scheld HH; Haverkamp W; Schulze-Bahr E; Eckardt L
Europace; 2012 Mar; 14(3):396-401. PubMed ID: 21979994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
